Spyre Therapeutics, Inc. SYRE Q1 2025 earnings
Reported May 8, 2025 · Before market open
Revenue-
EPS-$0.74Beat by $0.02
EPS estimate-$0.76
Next report
Aug 4, 2026 (In 6 days)EPS estimate-$0.71
Financials
Q1 2025Valuation & ratios
Segments
By segment
Versus estimates
Revenue
Diluted EPS
Ask the moment Spyre Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Spyre Therapeutics, Inc. report Q1 2025 earnings?
- Spyre Therapeutics, Inc. (SYRE) reported Q1 2025 earnings on May 8, 2025 before market open.
- What were Spyre Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Spyre Therapeutics, Inc. reported revenue of - and eps of $-0.74 for Q1 2025.
- Did Spyre Therapeutics, Inc. beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-0.76 by $0.02.
- How did Spyre Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 38.3% from $-1.20.
- Where can I find Spyre Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001636282-25-000049) directly on SEC EDGAR. The filing index links above go to sec.gov.